For about two decades, the choice of azithromycin vs doxycycline for chlamydia felt like a coin flip. Both worked. Both were cheap. One was a single dose you could swallow in the clinic before walking out the door, the other was a week of twice-daily pills. Most patients picked the one-and-done option, and most clinicians wrote for it.
That has quietly changed. The CDC’s 2021 STI Treatment Guidelines moved doxycycline to the top of the list for uncomplicated genital chlamydia, with azithromycin demoted to an alternative. The reason is not that azithromycin stopped working. It’s that the data on doxycycline got better, especially for infections people don’t talk about as often.
So which one should you actually take? Honest answer: it depends on where the infection is, whether you’ll finish a 7-day course, and whether you’re pregnant. Here’s how the comparison breaks down.
How Each Antibiotic Works
Both drugs stop Chlamydia trachomatis from making the proteins it needs to replicate, but they belong to different classes. Azithromycin is a macrolide. Doxycycline is a tetracycline. They bind to different parts of the bacterial ribosome and reach different concentrations in different tissues, which turns out to matter more than anyone realized fifteen years ago.
Azithromycin is famous for its long half-life. One 1-gram oral dose stays active in tissue for roughly a week. Doxycycline clears faster, which is why the standard course is 100 mg twice daily for 7 days.
Cure Rates: What the Head-to-Head Data Actually Shows
For uncomplicated urogenital chlamydia in women, both drugs cure roughly 97 to 98 percent of infections. That part of the azithromycin vs doxycycline debate is basically a tie.
The gap opens up in two specific situations:
- Rectal chlamydia. A meta-analysis published in Clinical Infectious Diseases found doxycycline cured about 100 percent of rectal infections, while azithromycin cured around 82 percent. That’s a meaningful difference, and rectal infections are common in men who have sex with men and also in women who never report rectal symptoms.
- Symptomatic urethral infections in men. A 2021 NEJM randomized trial showed doxycycline outperformed azithromycin (100% vs 74% microbiologic cure) in men with urethral chlamydia.
That NEJM trial is essentially the paper that flipped the guidelines. When a one-week course cures 26 percentage points more infections than a single dose, the convenience argument loses.
Side Effects: Where They Differ
Both drugs are generally well tolerated, but they cause different complaints.
Azithromycin tends to produce:
- Nausea or stomach cramps within a few hours of the dose
- Diarrhea (the single 1-gram dose is more likely to do this than the multi-day Z-Pak)
- Rare but real QT prolongation in patients on other heart-rhythm drugs
Doxycycline tends to produce:
- Sun sensitivity. Real sunburn from a 15-minute walk is not unusual.
- Esophageal irritation if you take it lying down or without enough water
- Stomach upset, which is why many clinicians say take it with food (it’s slightly less absorbed that way, but still effective)
- Tooth discoloration in kids under 8 and contraindicated in pregnancy
For most healthy adults, the side effect profiles roughly cancel out. The deciding factor is usually pregnancy status, since doxycycline is off the table during pregnancy and azithromycin becomes the preferred drug.
Cost and Convenience
Both are generic and cheap. A 7-day supply of doxycycline 100 mg usually runs $10 to $20 at US pharmacies without insurance. A single 1-gram azithromycin dose is similar. You can compare current pricing on generic azithromycin and doxycycline at edrugstore.com if you want to see what your out-of-pocket cost will be.
The real cost question is adherence. If you know you’ll forget the second daily dose by day three, the single-dose azithromycin still has a role, even if cure rates run a bit lower. A 90 percent chance of cure with a pill you actually take beats a 98 percent chance with a regimen you abandon on day four.
Resistance, Reinfection, and the Bigger Picture
Chlamydia hasn’t developed clinically significant resistance to either antibiotic, which is unusual and lucky. The bigger issue is reinfection from an untreated partner. The CDC recommends retesting roughly three months after treatment regardless of which drug you used.
This matters because chlamydia and gonorrhea coinfection is common, and the treatment approach for gonorrhea has shifted dramatically. If you’re researching the broader STI picture, our breakdown of azithromycin vs doxycycline for gonorrhea explains why ceftriaxone now does most of that heavy lifting, and our piece on whether doxycycline still works for gonorrhea in 2026 covers the latest resistance data. For a deeper dive on the chlamydia-specific regimen, the article on doxycycline for chlamydia dosage and cure rates walks through the practical details.
Which One Should You Take?
A reasonable framework based on current evidence:
- Doxycycline 100 mg twice daily for 7 days for most non-pregnant adults, especially anyone with rectal exposure or symptomatic urethritis.
- Azithromycin 1 gram single dose for pregnant patients, for anyone who genuinely can’t complete a 7-day course, and for situations where directly observed therapy matters.
- Either is acceptable for uncomplicated urogenital chlamydia in non-pregnant women, with doxycycline now slightly preferred.
This is the kind of decision worth running past a pharmacist or prescriber who knows your full med list. Azithromycin interacts with several cardiac and psychiatric drugs through QT prolongation, and doxycycline interacts with antacids, iron, calcium, and warfarin.
The Bottom Line
The azithromycin vs doxycycline question for chlamydia used to be a tie. It isn’t anymore. Doxycycline edges ahead on cure rates, especially for rectal and symptomatic urethral infections, and that’s why guidelines now favor it. Azithromycin still has a clear role for pregnant patients and adherence concerns. Talk to your prescriber about which fits your situation, complete the full course, and get retested at three months so you’re not treating the same infection twice.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- CDC STI Treatment Guidelines: Chlamydial Infections, current first-line and alternative regimens.
- Doxycycline vs Azithromycin for Urogenital Chlamydia (NEJM 2021), randomized trial showing doxycycline superiority in men.
- CDC Chlamydia Fact Sheet, patient-facing information on testing, treatment, and follow-up.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More